Ephedrine Cycling

Rowley, Brian
August 2002
Joe Weider's Muscle & Fitness;Aug2002, Vol. 63 Issue 8, p78
Offers suggestions on the maximization of the effectivity of Ephedrine, a metabolism booster and fat burner. Danger in using excess amounts of Ephedrine; Information on ephedrine cycling; Characteristics of high-risk group advised not to use the compound.


Related Articles

  • controlled BURN. Sonnenburg, Beth // Joe Weider's Muscle & Fitness Hers;Feb/Mar2002, Vol. 3 Issue 1, p56 

    Examines the effectiveness of ephedrine-based fat burners, the risks involved and how to minimize the probability of experiencing adverse effects with the drugs. Definition and origin of ephedrine; Physiological effects; Amount of the right dosage.

  • What Is the Evidence that Riboflavin Can Be Used for Migraine Prophylaxis? Liebman, Tracey N.; Crystal, Sara C. // Einstein Journal of Biology & Medicine;2011, Vol. 27 Issue 1, p7 

    Individuals with migraine often have recurrent, painful symptoms, and symptomatic treatments have detrimental side effects and do not prevent further attacks. Studies indicate that riboflavin can be used to decrease headache frequency and lessen the need for symptomatic treatment. Mitochondrial...

  • Glibenclamide and cardio-metabolic risk: a systematic review. Derosa, Giuseppe; Maffioli, Pamela // International Journal of Diabetes in Developing Countries;Jun2014, Vol. 34 Issue 2, p61 

    The aim of this review is to evaluate the safety and efficacy of glibenclamide for the treatment of type 2 diabetes mellitus, in particular we evaluated glibenclamide effect on cardiovascular risk and metabolic control, and all causes of mortality. A systematic search strategy was developed to...

  • Long-term Efficacy of Insulin Pump Therapy in Children with Type 1 Diabetes Mellitus. Joshi Batajoo, Ruby; Messina, Catherine R.; Wilson, Thomas A. // Journal of Clinical Research in Pediatric Endocrinology;Sep2012, Vol. 4 Issue 3, p127 

    Objective: Insulin pumps have been well established for insulin delivery. However, questions about long-term efficacy of insulin pump therapy still remain. We evaluated the long-term efficacy of continuous insulin infusion pump therapy (CSII) in pediatric patients with type 1 diabetes mellitus...

  • The Metabolic Treatment of Patients with Coronary Artery Disease: Effects on Quality of Life and Effort Angina. César, L. A. M.; Gowdak, L. H.; Mansur, A. P. // Current Pharmaceutical Design;3/11/2009, Vol. 15 Issue 8, p841 

    The effectiveness of drug therapy in controlling angina and the resulting improvement in exercise capacity were reviewed. We performed a Medline search of published reports on ranolazine, trimetazidine, and other medicines that act metabolically. Quality of life with regards to work capacity...

  • A remedy for 'airplane ear' doesn't seem to work. Cerrato, Paul L. // RN;Aug99, Vol. 62 Issue 8, p87 

    Highlights the study `Pseudo-Ephedrine and Air Travel-Associated Ear Pain in Children,' by B.J. Buchanan, J. Hoagland and P.R. Fischer, published in a 1999 issue of `Archives of Pediatric Adolescent Medicine.' Effectiveness of drugs in preventing middle ear inflammation and pain during airplane...

  • First do no Harm: Promoting an Evidence-Based Approach to Atypical Antipsychotic use in Children and Adolescents. Panagiotopoulos, Constadina; Ronsley, Rebecca; Elbe, Dean; Davidson, Jana; Smith, Derryck H. // Journal of the Canadian Academy of Child & Adolescent Psychiatry;2010, Vol. 19 Issue 2, p124 

    Objectives: To review the evidence for efficacy and metabolic effects of atypical antipsychotics (AAPs), and to propose a metabolic monitoring protocol for AAP use in children and adolescents. Methods: A PubMed search was performed to obtain all studies related to efficacy, metabolic...

  • Protein Kinase C Inhibitors in the Treatment of Diabetic Retinopathy. Review. Gálvez, M. I. López // Current Pharmaceutical Biotechnology;Mar2011, Vol. 12 Issue 3, p386 

    No abstract available.

  • Antihistamine/decongestant.  // Geriatrics;June97, Vol. 52 Issue 6, p21 

    Announces the approval by the Food and Drug Administration of loratadine/pseudoephedrine sulfate for use in patients with seasonal allergic rhinitis and asthma.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics